Immuneering Corp is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IMRX is expected to report earnings to fall 1.05% to -37 cents per share on March 11
Q4'25
Est.
$-0.38
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.05
Q4'24
Missed
by $0.13
The last earnings report on November 12 showed earnings per share of -37 cents, beating the estimate of -40 cents. With 1.97M shares outstanding, the current market capitalization sits at 416.74M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMRX showed earnings on November 12, 2025. You can read more about the earnings report here.